Application:
Paricalcitol is an active Vitamin D2 analog for the Pharmaceutical industry. Paricalcitol is used for the treatment and prevention of secondary hyperparathyroidism associated with chronic kidney disease (CKD). It has been shown to reduce parathyroid hormone levels by inhibiting its synthesis and secretion.
Specification:
Names: Paricalcitol; 19-NOR-1α,25-dihydroxyergocalciferol; 19-NOR-1α,25-dihydroxy D2
Content Paricalcitol (HPLC) is 97.0-103.0%
CAS: 131918-61-1
Regulatory: DMF available (an ASMF has been filed and accepted in several European countries)
ARS - Working Standard:
Paricalcitol – CAS no. 131918-61-1
Available Impurities:
22Z-Paricalcitol – CAS no. 1884139-61-0
